Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Legislating CBD As Lawful Supplement Ingredient: A Threatening Precedent For US Industry?

Feb 19 2021

• By Malcolm Spicer

Related Content

Supplement Pre-market Approval Resurfaces From Blumenthal, Durbin

May 18 2016

US FDA Reopens Door For CBD Safety Data, But NPA Says Window Closing For Setting Safe Level

Mar 10 2020

CBD Regulation Bill Filed In US House Again; VMS In Pre-Tax Savings Accounts In First Senate Vote

Feb 05 2021

Additional Topics

United States US States Cannabidiol CBD Dietary Supplements Legislation Commercial Enforcement FDA Ingredients Policy Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.